Tevogen Bio Ownership | Who Owns Tevogen Bio?


OverviewFinancialsChart

Tevogen Bio Ownership Summary


Tevogen Bio is owned by 0.72% institutional investors, 77.31% insiders, and 21.97% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 0.61% of TVGN shares.

TVGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTevogen Bio0.72%77.31%21.97%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de1.19M0.61%$395.56K
Vanguard group1.13M0.58%$375.27K
Geode capital management553.22K0.28%$183.17K
Goldman sachs group273.69K0.14%$90.62K
Morgan stanley250.26K0.13%$82.86K
Northern trust189.95K0.10%$149.16K
Deutsche bank ag\173.73K0.09%$57.33K
State street115.10K0.06%$90.39K
Fmr106.01K0.06%$83.25K
Sei investments90.25K0.05%$29.88K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Abel hall14.17K0.01%$17.72K
Bridgeway capital management82.50K0.00%$64.79K
Virtu financial14.45K0.00%$11.00K
Tower research capital llc (trc)13.26K0.00%$10.41K
Stonex group10.93K0.00%$3.62K
Hrt financial lp52.24K0.00%$17.00K
China universal asset management---
Legal & general group3.15K-$1.04K
Price t rowe associates inc /md/18.66K-$15.00K
Proshare advisors---

Top Buyers

HolderShares% AssetsChange
Goldman sachs group273.69K-152.57K
Deutsche bank ag\173.73K-130.74K
Morgan stanley250.26K-123.60K
Hrt financial lp52.24K0.00%52.24K
Vanguard group1.13M-44.71K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de1.19M--357.45K
Xtx topco---58.81K
China universal asset management---34.48K
State street115.10K--28.69K
Bank of new york mellon32.74K--23.59K

New Positions

HolderShares% AssetsChangeValue
Hrt financial lp52.24K0.00%52.24K$17.00K
Virtu financial14.45K0.00%14.45K$11.00K
Stonex group10.93K0.00%10.93K$3.62K
Gamma investing2.06K-2.06K$684.00

Sold Out

HolderChange
True wealth design-20.00
Srs capital advisors-88.00
Nisa investment advisors-158.00
Headlands-341.00
Amalgamated bank-757.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20257-86.27%1,402,633-70.87%-10.48%6-73.91%1-94.74%
Sep 30, 202515-70.00%1,340,664-70.54%-9.15%4-85.71%7-46.15%
Jun 30, 2025548.00%4,803,63624.71%252.26%323.23%13-7.14%
Mar 31, 20251-97.50%50,000-97.83%-1.86%--100.00%--100.00%
Dec 31, 20244227.27%2,408,376-57.37%112.84%3233.33%6-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 09, 2025Saadi Ryan H. Chief Executive OfficerSell$1.77M
Mar 12, 2025Flomenberg Neal See RemarksSell$253.94K
Mar 11, 2025Flomenberg Neal See RemarksSell$73.76K
Mar 07, 2025Flomenberg Neal See RemarksSell$81.25K
Mar 10, 2025Flomenberg Neal See RemarksSell$76.72K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3--
2025 Q2-1
2025 Q1-7
2024 Q4-1

TVGN Ownership FAQ


Who Owns Tevogen Bio?

Tevogen Bio shareholders are primarily institutional investors at 0.72%, followed by 77.31% insiders and 21.97% retail investors. The average institutional ownership in Tevogen Bio's industry, Biotech Stocks , is 381.47%, which Tevogen Bio falls below.

Who owns the most shares of Tevogen Bio?

Tevogen Bio’s largest shareholders are Blackrock funding, inc. /de (1.19M shares, 0.61%), Vanguard group (1.13M shares, 0.58%), and Geode capital management (553.22K shares, 0.28%). Together, they hold 1.47% of Tevogen Bio’s total shares outstanding.

Does Blackrock own Tevogen Bio?

BlackRock is not among the top 10 institutional shareholders of Tevogen Bio.

Who is Tevogen Bio’s biggest shareholder by percentage of total assets invested?

Abel hall is Tevogen Bio’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 14.17K Tevogen Bio shares, valued at 17.72K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools